[Cushing's syndrome. Medical treatment of adrenal hypercorticism].
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000616:Aminoglutethimide / Q000627:therapeutic use*; D000732:Androstanols / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000188:drug therapy*; D003533:Cyproheptadine / Q000627:therapeutic use; D013196:Dihydrotestosterone / Q000031:analogs & derivatives*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008797:Metyrapone / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use*; D009570:Nitriles / Q000627:therapeutic use
D000732:Androstanols; D009570:Nitriles; D013196:Dihydrotestosterone; D000616:Aminoglutethimide; D003533:Cyproheptadine; D001971:Bromocriptine; D008939:Mitotane; C009954:trilostane; D006854:Hydrocortisone; D008797:Metyrapone
Les syndromes de Cushing. Thérapeutique médicale de l'hypercorticisme surrénalien.